Related Experiment Video

Updated: Aug 6, 2026

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes
12:11

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

Aflatoxin M1: in vitro preparation and comparative in vitro metabolism versus aflatoxin B1 in the rat and mouse

D W Rice, D P Hsieh

    Research Communications in Chemical Pathology and Pharmacology
    |March 1, 1982
    PubMed

    Insights

    A new biotransformation method enables aflatoxin M1 (AFM1) production for metabolism studies. AFM1 is metabolized slower than aflatoxin B1 (AFB1) in rats and mice, with fewer protein-bound metabolites.

    Area of Science:

    • Biochemistry
    • Toxicology
    • Pharmacology

    Background:

    • Aflatoxins are toxic fungal metabolites with significant health implications.
    • Understanding aflatoxin metabolism is crucial for assessing their toxicity.
    • Aflatoxin M1 (AFM1) is a major metabolite of aflatoxin B1 (AFB1) found in food.

    Purpose of the Study:

    • To develop a biotransformation method for producing AFM1 for metabolism studies.
    • To compare the metabolism of AFM1 and AFB1 in rat and mouse liver fractions.
    • To investigate the toxicological implications of AFM1's metabolic profile.

    Main Methods:

    • Microsomes from 3-methylcholanthrene (3MCA) pretreated rats were used for biotransformation.
    • Postmitochondrial supernatant (S-10) fractions from mouse and rat hepatocytes were used for metabolism assays.
    • Metabolites were analyzed based on their solubility (aqueous, chloroform-extractable) and protein binding.

    Main Results:

    • A rapid and cost-effective method for AFM1 production was established.
    • AFM1 was metabolized more slowly than AFB1 in both rat and mouse S-10 fractions.
    • AFM1 metabolites were primarily in the aqueous fraction, with minimal S-10 protein binding, unlike AFB1.

    Conclusions:

    • The developed biotransformation method allows for sufficient AFM1 production for research.
    • AFM1 exhibits a distinct metabolic profile compared to AFB1, characterized by slower metabolism and reduced protein binding.
    • The reduced protein binding and slower metabolism of AFM1 may have implications for its toxicological effects.

    More Related Videos

    Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.09:21

    Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.

    Published on: February 15, 2019

    Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure08:25

    Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

    Published on: June 5, 2020

    Related Concept Videos

    Toxicity Testing in Animals01:23

    Toxicity Testing in Animals

    Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...